Vascular Health Screening
- Heart disease
- Cholesterol disorders
- High blood pressure (hypertension)
- Diabetes
What Happens During the Vascular Screening?
Ultrasound is used to measure the thickness of the walls of your carotid arteries, also known as carotid intima-media thickness, or "CIMT." This is a safe, non-invasive test in which you lie flat for 20-30 minutes. A small amount of gel is applied to your neck. We will use sound beams to assess your carotid artery, because as the walls of your carotid artery become thicker, your risk of having a heart attack or stroke increases.
CIMT measurement offers several advantages over the electron beam or computed helical tomography (EBCT or HeCT), commonly called a "heart scan." CIMT does not involve exposure to radiation, it is less expensive than a heart scan and it is a proven predictor of cardiovascular risk.
Learn more about CIMT Measurement for "Vascular Age"
Interpreting the Test
Using the results of the vascular health screening test, a cardiovascular disease prevention specialist will provide expert, personalized guidance concerning exercise, diet, smoking cessation and control of your risk factors for heart and blood vessel disease.
Questionnaires, computer programs and measurement of your body mass index, blood pressure, cholesterol and blood sugar levels also are used in your post-screening counseling session. If you have not had a complete cholesterol panel and blood sugar level measured in the past three months, we will ask you to have fasting blood work prior to your meeting. The cost of these blood tests is included in the screening fee.
How to Sign Up for Screening
Your physician must order the vascular health screening tests for you, and can do so by calling (608) 263-7420.
Cost
The charge for vascular health screening is $295. In the Madison area, insurance coverage usually is provided by Unity, Group Health Cooperative or Physicians Plus if patients meet all of the following criteria:
- The patient is referred by his or her primary care physician
- The patient does not have known atherosclerotic vascular disease
- The patient is 40 to 70 years old
- The patient has "intermediate" risk, defined as a 10-year risk of myocardial infarction or coronary death of 10-20 percent, or 6-20 percent for patients with a family history of premature heart disease
These definitions are outlined in the NCEP ATP III Guidelines and the Framingham risk prediction algorithm in those guidelines. Please check with your provider.
Payment for all charges related to the Vascular Health Screening Program must be made prior to testing. A report of the tests and risk assessment session will be sent to your ordering physician. You will get a copy of the report at the time of your personalized counseling session.


